Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.562, 2008-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Consider universal hep A vax in China
Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. :
Access to resources
Recommend
Hep B vax not linked to childhood-onset MS
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
Universal two-dose MMRV vax a viable prospect in Germany
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 542, 2007-01 ,pp. :
Universal two-dose MMRV vax a viable prospect in Germany
Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. :
Universal hep A vaccination worth it in Canada?
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :